Literature DB >> 29302849

Low Vs. High Alcohol: Central Benefits Vs. Detriments.

Yousef Tizabi1, Bruk Getachew2, Clifford L Ferguson2, Antonei B Csoka3, Karl M Thompson4, Alejandra Gomez-Paz5, Jana Ruda-Kucerova6, Robert E Taylor2.   

Abstract

The dose-dependent effects of alcohol, where the initial euphoric and stimulant effects initiated by the exposure to low ethanol levels can quickly lead to a deadly consequence are well established. Thus, high blood alcohol concentration (BAC), as seen in alcoholics, can cause significant damage to various organs. At low concentrations (e.g., 10 mg% or lower), however, beneficial effects of alcohol, particularly on cardiovascular function have been reported. Although, the latter assertion has been challenged by recent epidemiological studies, protective effects of low alcohol concentrations in vitro and in vivo relevant to the central nervous system (CNS) is well documented. In this review, the mechanism(s) leading to the detrimental effects of high BAC, as well as the beneficial effects of low BAC will be discussed. In addition, gender consideration is touched upon. Although further investigation is clearly warranted, it may be concluded that at least some of the beneficial outcomes of low BAC, including possible neuroprotection and antidepressant-like effects, may be due to elevation of the neurotropic factors and reduction of inflammatory mediators, whereas detrimental outcomes associated with high BAC, including neurotoxicity and depressive-like behavior may be due to reduction in neurotropic factors and elevation of inflammatory mediators. Furthermore, new research strategies are suggested.

Entities:  

Keywords:  Inflammatory mediators; Major depressive disorder; Neuroprotection; Neurotoxicity; Neurotrophic factors; Sex differences

Mesh:

Substances:

Year:  2018        PMID: 29302849     DOI: 10.1007/s12640-017-9859-x

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  126 in total

1.  Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats.

Authors:  S Arancibia; M Silhol; F Moulière; J Meffre; I Höllinger; T Maurice; L Tapia-Arancibia
Journal:  Neurobiol Dis       Date:  2008-07-15       Impact factor: 5.996

2.  Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine.

Authors:  Sriparna Ghosal; Eunyoung Bang; Wenzhu Yue; Brendan D Hare; Ashley E Lepack; Matthew J Girgenti; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2017-06-23       Impact factor: 13.382

3.  Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.

Authors:  Alexander Storch; Stefanie Ott; Yu I Hwang; Rainer Ortmann; Andreas Hein; Stefan Frenzel; Kazuo Matsubara; Shigeru Ohta; Hans Uwe Wolf; Johannes Schwarz
Journal:  Biochem Pharmacol       Date:  2002-03-01       Impact factor: 5.858

Review 4.  Sex differences in brain-derived neurotrophic factor signaling and functions.

Authors:  Chi Bun Chan; Keqiang Ye
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 5.  MicroRNAs regulate synaptic plasticity underlying drug addiction.

Authors:  A C W Smith; P J Kenny
Journal:  Genes Brain Behav       Date:  2017-10-10       Impact factor: 3.449

Review 6.  Ethanol-Associated Changes in Glutamate Reward Neurocircuitry: A Minireview of Clinical and Preclinical Genetic Findings.

Authors:  Richard L Bell; Sheketha R Hauser; Jeanette McClintick; Shafiqur Rahman; Howard J Edenberg; Karen K Szumlinski; William J McBride
Journal:  Prog Mol Biol Transl Sci       Date:  2015-11-24       Impact factor: 3.622

Review 7.  Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.

Authors:  Makoto Naoi; Wakako Maruyama; Georgy M Nagy
Journal:  Neurotoxicology       Date:  2004-01       Impact factor: 4.294

8.  Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial.

Authors:  Lara A Ray; Spencer Bujarski; Steve Shoptaw; Daniel Jo Roche; Keith Heinzerling; Karen Miotto
Journal:  Neuropsychopharmacology       Date:  2017-01-16       Impact factor: 8.294

9.  Long-Term Effects of Intermittent Adolescent Alcohol Exposure in Male and Female Rats.

Authors:  Eva M Marco; Sara Peñasco; María-Donina Hernández; Anabel Gil; Erika Borcel; Marta Moya; Elena Giné; José Antonio López-Moreno; Consuelo Guerri; Meritxell López-Gallardo; Fernando Rodríguez de Fonseca
Journal:  Front Behav Neurosci       Date:  2017-11-28       Impact factor: 3.558

10.  Effects of Intermittent Alcohol Exposure on Emotion and Cognition: A Potential Role for the Endogenous Cannabinoid System and Neuroinflammation.

Authors:  Laura Sanchez-Marin; Francisco J Pavon; Juan Decara; Juan Suarez; Ana Gavito; Estela Castilla-Ortega; Fernando Rodriguez de Fonseca; Antonia Serrano
Journal:  Front Behav Neurosci       Date:  2017-02-07       Impact factor: 3.558

View more
  4 in total

1.  Protective Effects of Donepezil Against Alcohol-Induced Toxicity in Cell Culture: Role of Caspase-3.

Authors:  Bruk Getachew; Tamaro Hudson; Thomas Heinbockel; Antonei B Csoka; Yousef Tizabi
Journal:  Neurotox Res       Date:  2018-05-26       Impact factor: 3.911

2.  Antidepressant effects of moxidectin, an antiparasitic drug, in a rat model of depression.

Authors:  Bruk Getachew; Yousef Tizabi
Journal:  Behav Brain Res       Date:  2019-09-09       Impact factor: 3.332

Review 3.  Non-pharmacological factors that determine drug use and addiction.

Authors:  Serge H Ahmed; Aldo Badiani; Klaus A Miczek; Christian P Müller
Journal:  Neurosci Biobehav Rev       Date:  2018-09-01       Impact factor: 8.989

4.  Reinforcement History Dependent Effects of Low Dose Ethanol on Reward Motivation in Male and Female Mice.

Authors:  Kathleen G Bryant; Binay Singh; Jacqueline M Barker
Journal:  Front Behav Neurosci       Date:  2022-04-11       Impact factor: 3.617

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.